Pelthos Therapeutics PTHS Insider Ownership

NYSE PTHS

$20.45 +0.19 (+0.94%)

As of: Oct 20, 2026 · 3:52 PM EDT

Insider Holdings by Owner

413.25K Shares

Insider Ownership Statistics

as of 30 Sep, 2026

Insider Ownership

55.09%

▼-0.058% pp QoQ

Shares Held by Insiders

2.05Mn

filed for Sep 2026

▼-0.10% QoQ

Shares Outstanding

3.72Mn

3,718,624 shares

Direct Holdings

404.07K

Indirect: 1.64Mn

Net Shares Traded (QoQ)

-2.14K

net selling in Sep 2026

Insiders Holding Shares

with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding

Latest —

Average ownership —

Peak ownership —

Shares Purchased/Sold by Insiders

Bought Sold

Latest quarter —

Net over range —

Buying quarters —

Insider Ownership Summary

Updated Oct 10, 2026

In the last 12 months, insiders at Pelthos Therapeutics made open-market purchases of $999,983 (35.95K shares) and open-market sales of $486,272 (18.8K shares).

By number of insiders, Pelthos Therapeutics saw one insider buy and 5 insiders sell on the open market over the past 12 months.
Among Pelthos Therapeutics' insiders, the largest open-market purchases in the past 12 months were by Todd C. Davis (Director), totaling $999,983 (35.95K shares), most recently on June 11, 2026.
Meanwhile, the largest open-market sales of PTHS in the past 12 months were by Ezra M. Friedberg (Director), totaling $325,792 (11.96K shares), most recently on October 2, 2026.
Peter Greenleaf (Director) made the most recent open-market trade by an insider of Pelthos Therapeutics, a sale of 797 shares for $16,872 on October 2, 2026.
Outside the open market, Pelthos Therapeutics insiders received 12K shares in stock awards, gave up 144 shares to cover taxes or exercise prices and gave away 9.54K shares as gifts over the past 12 months.
Per Business Quant data, Pelthos Therapeutics insiders hold 2.05Mn shares in total based on their latest Form 4 filings, or 55.03% of the 3.72Mn shares outstanding; that total is down 0.21% from 2.05Mn shares at the end of Q2 2026.
By type of ownership, PTHS insiders hold 19.64% of their shares directly (401.93K shares) and 80.36% indirectly (1.64Mn shares).
Holdings in Pelthos Therapeutics stock are reported by 8 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
PTHS's three largest insider shareholders, per their latest Form 4 filings, are Todd C. Davis (Director, 1.58Mn shares), Ezra M. Friedberg (Director, 202.56K shares) and Ligand Pharmaceuticals Inc (10% owner, 150K shares).
The largest insider, Todd C. Davis, holds 77.01% of PTHS's insider total.
In the past year, 7 insiders of Pelthos Therapeutics submitted 17 Form 4 filings reporting trades, awards or other transactions.
The insider holdings and trades above for Pelthos Therapeutics reflect Form 4 filings through October 6, 2026.

Form 4 Holdings

Insiders Holding PTHS

Insiders 8

Shares held 413.25K

Of outstanding 11.11%

#	Insider	Position	Direct	Indirect	Total	Share of Insiders	Last Filed
1	Pharmaceuticals Inc Ligand	TenPercentOwner	150,000	0	150,000	36.3%	02 Jul, 2025
2	Ezra M Friedberg	Director	80,484	0	80,484	19.5%	06 Oct, 2026
3	Todd C Davis	Director	75,834	0	75,834	18.4%	15 Jun, 2026
4	Knuettel Ii Francis	Cfo, Treas Secty	19,525	11,316	30,841	7.5%	26 May, 2026
5	Richard Malamut	Director	27,422	0	27,422	6.6%	06 Apr, 2026
6	Peter Greenleaf	Director	23,087	0	23,087	5.6%	06 Oct, 2026
7	Matthew Pauls	Director	13,578	0	13,578	3.3%	06 Oct, 2026
8	Andrew J. Einhorn	Director	12,000	0	12,000	2.9%	29 Dec, 2025

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

95 Insider Transactions

Source SEC Form 4

Latest quarter Sep 2026

Date	Insider	Position	Transaction	Shares	Price	Value	Shares Held After	Ownership
02 Oct, 2026	Ezra M Friedberg	Director	Disposed S	558	$20.72	$11.56K	80,484	Direct
02 Oct, 2026	Peter Greenleaf	Director	Disposed S	797	$21.17	$16.87K	23,087	Direct
02 Oct, 2026	Matthew Pauls	Director	Disposed S	786	$21.00	$16.51K	13,578	Direct
02 Jul, 2026	Ezra M Friedberg	Director	Disposed S	534	$26.03	$13.90K	81,066	Direct
02 Jul, 2026	Matthew Pauls	Director	Disposed S	692	$26.00	$17.99K	14,458	Direct
02 Jul, 2026	Peter Greenleaf	Director	Disposed S	712	$26.00	$18.51K	23,969	Direct
02 Jul, 2026	Ezra M Friedberg	Director	Disposed S	24	$27.33	$656	81,042	Direct
02 Jul, 2026	Matthew Pauls	Director	Disposed S	94	$27.36	$2.57K	14,364	Direct
02 Jul, 2026	Peter Greenleaf	Director	Disposed S	85	$27.27	$2.32K	23,884	Direct
15 Jun, 2026	Ezra M Friedberg	Director	Disposed S	224	$27.12	$6.08K	81,659	Direct
15 Jun, 2026	Ezra M Friedberg	Director	Disposed S	59	$27.94	$1.65K	81,600	Direct
11 Jun, 2026	Todd C Davis	Director	Acquired P	35,445	$27.80	$985.53K	75,331	Direct
11 Jun, 2026	Todd C Davis	Director	Acquired P	503	$28.73	$14.45K	75,834	Direct
22 May, 2026	Knuettel Ii Francis	Cfo, Treas Secty	Disposed D	13,947	$0.00	$0	19,525	Direct
22 May, 2026	Knuettel Ii Francis	Cfo, Treas Secty	Disposed S	1,500	$26.84	$40.26K	11,316	Indirect
22 May, 2026	Knuettel Ii Francis	Cfo, Treas Secty	Acquired A	59,500	—	—	59,500	Direct
22 May, 2026	Knuettel Ii Francis	Cfo, Treas Secty	Disposed D	42,500	—	—	0	Direct
14 May, 2026	Ezra M Friedberg	Director	Disposed F	144	$27.01	$3.89K	81,883	Direct
02 Apr, 2026	Peter Greenleaf	Director	Disposed S	420	$20.52	$8.62K	25,058	Direct
02 Apr, 2026	Matthew Pauls	Director	Disposed S	415	$20.52	$8.51K	15,521	Direct

Showing 1 to 20 of 95 transactions